New pill aims to fight hard-to-treat cancers and brain tumors

NCT ID NCT06012695

First seen May 02, 2026 · Last updated May 06, 2026 · Updated 1 time

Summary

This study tests an experimental oral drug called NBM-BMX in people with advanced solid tumors or newly diagnosed glioblastoma (a type of brain cancer). In one group, the drug is given alone to patients whose cancer has stopped responding to standard treatments. In another group, it is combined with radiation and chemotherapy for newly diagnosed brain cancer patients. The goal is to find safe doses and see if the drug helps control the cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    NOT_YET_RECRUITING

    Kaohsiung City, 807, Taiwan

    Contact Phone: •••-•••-••••

  • Koo Foundation Sun Yat-Sen Cancer Center

    RECRUITING

    Taipei, 112, Taiwan

    Contact Phone: •••-•••-••••

  • Linkou Chang-Gung Memorial Hospital

    RECRUITING

    Taoyuan City, 333, Taiwan

    Contact Phone: •••-•••-••••

  • Taichung Veterans General Hospital

    RECRUITING

    Taichung, 407, Taiwan

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.